Post-Operative Pain - Pipeline Review, H1 2018

  • ID: 4451698
  • Report
  • 218 pages
  • Global Markets Direct
1 of 5

FEATURED COMPANIES

  • Abide Therapeutics Inc
  • Cara Therapeutics Inc
  • Heron Therapeutics Inc
  • Lipocure Ltd
  • Orion Corporation
  • Recro Pharma Inc
  • MORE
Post-Operative Pain - Pipeline Review, H1 2018

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H1 2018, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape.

Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics.

Report Highlights

The latest Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 5, 1, 8, 18, 8, 1, 21, 3 and 3 respectively. Similarly, the Universities portfolio in Phase III and Preclinical stages comprises 1 and 1 molecules, respectively.

Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from our proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System)
  • The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities
  • The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects
  • The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects
  • The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System)
Reasons to Buy:
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Find and recognize significant and varied types of therapeutics under development for Post-Operative Pain (Central Nervous System)
  • Classify potential new clients or partners in the target demographic
  • Develop tactical initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics
  • Formulate corrective measures for pipeline projects by understanding Post-Operative Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abide Therapeutics Inc
  • Cara Therapeutics Inc
  • Heron Therapeutics Inc
  • Lipocure Ltd
  • Orion Corporation
  • Recro Pharma Inc
  • MORE
Introduction

Post-Operative Pain - Overview

Post-Operative Pain - Therapeutics Development

Post-Operative Pain - Therapeutics Assessment

Post-Operative Pain - Companies Involved in Therapeutics Development

Post-Operative Pain - Drug Profiles

Post-Operative Pain - Dormant Projects

Post-Operative Pain - Discontinued Products

Post-Operative Pain - Product Development Milestones

Appendix

List of Tables

Number of Products under Development for Post-Operative Pain, H1

Number of Products under Development by Companies, H1

Number of Products under Development by Universities/Institutes, H1

Products under Development by Companies, H1

Products under Development by Universities/Institutes, H1

Number of Products by Stage and Target, H1

Number of Products by Stage and Mechanism of Action, H1

Number of Products by Stage and Route of Administration, H1

Number of Products by Stage and Molecule Type, H1

Post-Operative Pain - Pipeline by Abide Therapeutics Inc, H1

Post-Operative Pain - Pipeline by AcelRx Pharmaceuticals Inc, H1

Post-Operative Pain - Pipeline by Adynxx Inc, H1

Post-Operative Pain - Pipeline by AngioChem Inc, H1

Post-Operative Pain - Pipeline by Aoxing Pharmaceutical Company Inc, H1

Post-Operative Pain - Pipeline by Apsen Farmaceutica SA, H1

Post-Operative Pain - Pipeline by Cadila Healthcare Ltd, H1

Post-Operative Pain - Pipeline by Camurus AB, H1

Post-Operative Pain - Pipeline by Cara Therapeutics Inc, H1

Post-Operative Pain - Pipeline by Center Laboratories Inc, H1

Post-Operative Pain - Pipeline by Colby Pharmaceutical Co, H1

Post-Operative Pain - Pipeline by Cytogel Pharma LLC, H1

Post-Operative Pain - Pipeline by Dompe Farmaceutici SpA, H1

Post-Operative Pain - Pipeline by Eupraxia Pharmaceuticals Inc, H1

Post-Operative Pain - Pipeline by EyeGate Pharmaceuticals Inc, H1

Post-Operative Pain - Pipeline by Fujimoto Pharmaceutical Corp, H1

Post-Operative Pain - Pipeline by GW Pharmaceuticals Plc, H1

Post-Operative Pain - Pipeline by Heron Therapeutics Inc, H1

Post-Operative Pain - Pipeline by Immupharma Plc, H1

Post-Operative Pain - Pipeline by Innocoll AG, H1

Post-Operative Pain - Pipeline by Insys Therapeutics Inc, H1

Post-Operative Pain - Pipeline by Ionis Pharmaceuticals Inc, H1

Post-Operative Pain - Pipeline by iX Biopharma Ltd, H1

Post-Operative Pain - Pipeline by Lipocure Ltd, H1

Post-Operative Pain - Pipeline by Liquidia Technologies Inc, H1

Post-Operative Pain - Pipeline by Lumosa Therapeutics Co Ltd, H1

Post-Operative Pain - Pipeline by Medtronic Plc, H1

Post-Operative Pain - Pipeline by Mundipharma International Ltd, H1

Post-Operative Pain - Pipeline by Neumentum Inc, H1

Post-Operative Pain - Pipeline by Novartis AG, H1

Post-Operative Pain - Pipeline by Ocular Therapeutix Inc, H1

Post-Operative Pain - Pipeline by Orion Corporation, H1

Post-Operative Pain - Pipeline by Pacira Pharmaceuticals Inc, H1

Post-Operative Pain - Pipeline by PainReform Ltd, H1

Post-Operative Pain - Pipeline by Pharmaleads SA, H1

Post-Operative Pain - Pipeline by PhytoHealth Corp, H1

Post-Operative Pain - Pipeline by PixarBio Corp, H1

Post-Operative Pain - Pipeline by RaQualia Pharma Inc, H1

Post-Operative Pain - Pipeline by Recro Pharma Inc, H1

Post-Operative Pain - Pipeline by Relmada Therapeutics Inc, H1

Post-Operative Pain - Pipeline by Serina Therapeutics Inc, H1

Post-Operative Pain - Pipeline by SteadyMed Therapeutics Inc, H1

Post-Operative Pain - Pipeline by Taiwan Liposome Company Ltd, H1

Post-Operative Pain - Pipeline by Teikoku Pharma USA Inc, H1

Post-Operative Pain - Pipeline by Trevena Inc, H1

Post-Operative Pain - Pipeline by Xigen SA, H1

Post-Operative Pain - Dormant Projects, H1

Post-Operative Pain - Discontinued Products, H1

List of Figures

Number of Products under Development for Post-Operative Pain, H1

Number of Products under Development by Companies, H1

Number of Products under Development by Universities/Institutes, H1

Number of Products by Top 10 Targets, H1

Number of Products by Stage and Top 10 Targets, H1

Number of Products by Top 10 Mechanism of Actions, H1

Number of Products by Stage and Top 10 Mechanism of Actions, H1

Number of Products by Top 10 Routes of Administration, H1

Number of Products by Stage and Top 10 Routes of Administration, H1

Number of Products by Molecule Types, H1

Number of Products by Stage and Molecule Types, H
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Abide Therapeutics Inc
  • AcelRx Pharmaceuticals Inc
  • Adynxx Inc
  • AngioChem Inc
  • Aoxing Pharmaceutical Company Inc
  • Apsen Farmaceutica SA
  • Cadila Healthcare Ltd
  • Camurus AB
  • Cara Therapeutics Inc
  • Center Laboratories Inc
  • Colby Pharmaceutical Co
  • Cytogel Pharma LLC
  • Dompe Farmaceutici SpA
  • Eupraxia Pharmaceuticals Inc
  • EyeGate Pharmaceuticals Inc
  • Fujimoto Pharmaceutical Corp
  • GW Pharmaceuticals Plc
  • Heron Therapeutics Inc
  • Immupharma Plc
  • Innocoll AG
  • Insys Therapeutics Inc
  • Ionis Pharmaceuticals Inc
  • iX Biopharma Ltd
  • Lipocure Ltd
  • Liquidia Technologies Inc
  • Lumosa Therapeutics Co Ltd
  • Medtronic Plc
  • Mundipharma International Ltd
  • Neumentum Inc
  • Novartis AG
  • Ocular Therapeutix Inc
  • Orion Corporation
  • Pacira Pharmaceuticals Inc
  • PainReform Ltd
  • Pharmaleads SA
  • PhytoHealth Corp
  • PixarBio Corp
  • RaQualia Pharma Inc
  • Recro Pharma Inc
  • Relmada Therapeutics Inc
  • Serina Therapeutics Inc
  • SteadyMed Therapeutics Inc
  • Taiwan Liposome Company Ltd
  • Teikoku Pharma USA Inc
  • Trevena Inc
  • Xigen SA
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll